Chestnut Ridge, NY, United States of America

Sridhar Krishna Rabindran

This inventor holds 9 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignees: Wyeth, The General Hospital Corporation, American Cyanamid Company. Active years: 2002-2020.

USPTO Granted Patents = 9 (Patent Applications = 4)

% Patents Active = 88.9

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 104(Granted Patents)

Location History:

Chestnut Ridge, NY (US) (2002 - 2020)
Eagleville, PA (US) (2020)

Company Filing History:

The General Hospital Corporation

patents

1 out of 3,580

American Cyanamid Company

patents

4. 1 out of 113

Wyeth Holdings Corporation

patents

where one patent can have more than one assignee

Years Active: 2002-2020

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10729672 - Antineoplastic combinations with mTOR inhibitor, trastuzumab and/or HKI-272 (2020-08-04),

2. 10603314 - Method for treating gefitinib resistant cancer (2020-03-31),

3. 10596162 - Method for treating gefitinib resistant cancer (2020-03-24),

4. 7982043 - Protein tyrosine kinase enzyme inhibitors (2011-07-19),

5. 7399865 - Protein tyrosine kinase enzyme inhibitors (2008-07-15),

6. RE40418 - Treatment of neoplasms with CCI-779/EKB-569 combination (2008-06-30),

7. 6878737 - Reversal of multidrug resistance in human colon carcinoma cells (2005-04-12),

8. 6617333 - Antineoplastic combinations comprising (2003-09-09),

9. 6372775 - Reversal of multidrug resistance in human colon carcinoma cells (2002-04-16),

I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents.

Profile summary based on public USPTO records.